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ABSTRACT 
Objective: Different ailments can be treated by multiple approaches. Since ancient civilization plant material have been used successfully for 
treating diseases. Plants contain active ingredients which are beneficial for treatment of multiple diseases. The purpose of the study was to evaluate 
the neuropharmacological effects of ethanolic extract of fruit of Piper chaba. 
Methods: Piper chaba’s ethanolic extract was diluted in DMSO and administered orally at 300mg/kg according to weight of mice for 21 days. A 
number of tests were then performed to evaluate CNS activity. 
Results: The results showed reduced number of cage crossing, head dips, decreased central and peripheral square crossing, reduced struggling time 
in forced swim test and decreased time spends in light and dark test. 
Conclusion: From our results it is concluded that after acute dosing ethanolic extract of fruit of Piper chaba possesses CNS depressant, mild 
anxiolytic and sedative effect.  
Keywords: Piper chaba, Piperaceae, Anxiolytic, Sedative, Depressant, GABA (Gamma amino butyric acid), DMSO (Dimethyl Sulfoxide).  
 
INTRODUCTION 
Phytochemicals are synthesized by plants which are chemical 
substances used in ailments of different diseases [1]. Antioxidants 
are part of phytochemicals which possesses biological activities such 
as reduction in risk of cancer, aging etc [2]. Plants had been used for 
healthcare and medicinal purposes long before it was recorded in 
history [3]. Studies reveal that the clinical settings in Europe and 
USA have a very low rate of prescribing herbal medicine but recently 
herbal medicines have regained their popularity because of the 
availability of scientific evidence supporting the effectiveness and 
safety of herbal medicine [4]. 
Piper is an ecologically and economically important genus in family 
Piperaceae [5]. Most piper species are herbaceous climbers or vines; 
some grow as shrubs while others grow as small trees [6]. Family 
Piperaceae has found the great deal of applications in the traditional 
pharmacopeias of several cultural groups such as Indian ayurvedic 
system, Chinese herbal medicine, as well as in Latin, African, 
American and West Indies medicine [7]. 
The plant Piper chaba grows yearly and is a lasting shrub [8]. A 
phytochemical analysis was performed on Piper chaba hunter. The 
major components of stem bark are: Piperine, Piperanine, 
Pipernonaline, Dehydropipernonaline, Piperlonguminine, 
Retrofractamide B, Guineensine, N-isobutyl-(2E, 4E)-
octadecadienamide, N-isobutyl-(2 E, 4 E, 14 Z)-eicosatrienamide, 
Lignan [9] and alkaloids such as piperamine 2, 4-decadienoic acid 
piperidide, kusunokinin and pellitorine [10]. A unique piperine 
dimer CHABAMIDE has also been isolated from stem bark [11].  
Some alkamides are reported to be present in the root of Piper chaba 
such as: Piperine, Piplartine, Piperlonguminine, Sylvatine and β-
sitosterol [12]. The fruit oil of Piper chaba contains caryophyllene 
oxide, β-caryophyllene, few monoterpenes hydrocarbons, high 
amount of aliphatic hydrocarbons and moderate content of 
sesquiterpenes [13].  
Piper chaba has been used in traditional medicine as carminative, 
stimulant, anti-hypertensive, muscle relaxant [14]. Stem is useful in 
diarrhea, arthritis and rheumatic pains [15]. The fruit of Piper chaba 
has shown a lot of potential in traditional medicine. It is used as an 
anti-flatulent, gastro-protective, appetizing property, as an 
expectorant, anti-tussive, anti-fungal agent. It also possesses 
cholesterol lowering properties [16]. 
The activities exhibited by Piper chaba fruits are anti-inflammation, 
chemoprevention, hepatoprotection, antiangiogenesis, adipogenesis 
and immunomodulation [17]. In Ayurveda its stem has shown 
diuretic, anti-inflammatory, analgesic, antidiarrheal and CNS 
depressant activity in mice [18]. The methanol and ethanol extract 
of stem bark at 125mg, 250mg and 500mg/kg dose dependently, 
decreased carrageenan induced paw edema in rat and increased 
pentobarbitone induced sleeping time in mice [19]. The aim of an 
above study is to determine neuropharmacological effects of 
ethanolic extract of fruit of Piper chaba after acute dosing in order to 
gain knowledge about its efficacy and toxicity. 
MATERIALS AND METHODS 
Plant Collection 
The plant Piper chaba was provided by Dr. Iqbal Azhar Department 
of Pharmacognosy University of Karachi. 
Extraction of plant material 
Inorder to reduce the microbial load the plant was first washed with 
water. The fruit of Piper chaba was cut into small pieces and dried at 
50°C, and then they were powdered and extracted. Next this 
powdered material was macerated with 95% ethanol for 3 days. It 
was then filtered and reduced to dryness under pressure. The 
process of maceration was repeated twice and then dried using 
evaporator. 
Selection of animal’s 
For screening of CNS parameters 20-26 gm albino mice of either sex 
bred at animal house of the Department of Pharmacology, University 
of Karachi was used. The mice were given a standard diet ad libitum 
and water for 21 days. The environmental conditions were kept 
constant i. e 23+2°C.[20] All animals were equally divided into three 
groups, one group served as control, second as standard 
(lorazepam) and third as treated with ethanolic extract of Piper 
chaba. Animals were handled as per specifications provided in 
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Helsinki Resolution 1964 and study was approved by our Board of 
advanced studies and research vides Resol. NO.10 (6) dated 26-09-
2012 & 16-10-2012. 
Dosing protocol  
The dosing of Piper chaba was done on the daily basis. Ethanolic 
extract of fruit of Piper chaba was taken and the dose was taken as: 
Piper chaba 300mg/kg (for acute dosing) [21] so dose adjusted 
according to weight of mice in milligrams. Standard solution was 
prepared of 250mg/10 ml in DMSO and dose was given orally in 
milliliter (ml) by the serial dilution method. 
Control mice were given similar milliliter (ml) of DMSO. 
Standard drug used was Lorazepam 2mg/60kg that means 0.3 
mg/kg. This dose was adjusted according to weight of mice in 
milligrams. Stock solution was prepared 12mg/60 ml in DMSO and 
dose was administered by the serial dilution method orally. 
CNS screening test 
Cage crossing test 
For monitoring exploratory behavior of mice transparent, plexiglass cage 
(26×26×26 cm) with saw dust covered floor was used. The mice of all 3 
groups were placed in an apparatus for 5 minutes to get them 
customized with apparatus. After they got acquainted with the setting, 
the numbers of cage crossings were counted for 5 minutes [22]. 
Head dip test  
Another exploratory behavioral test used for evaluation of different 
anxiety related activity in rodents is hole board or head dip test. The 
apparatus consists of an enclosed wooden rectangular box (35 
cm×45 cm×45 cm).  
The holes are 2.5 cm in diameter and found in all walls. [23] The 
mice that were not customized with the apparatus were placed in 
the central area and allowed to freely explore for 5 minutes. The 
number of times the mouse stuck out its snout was noted [24]. 
Forced swim test 
It measures the antidepressant effects of drugs. It is maintained at 
22-25°C and consists of the cylindrical container made of glass 
containing 8 cm water [42] the mouse is placed in such way, that 
feet of animal do not touch the bottom.  
The test is based on the assumption that the animal will swim 
actively inorder to escape from stressful stimuli. Animal shows state 
of despair when it stops swimming and floats on surface. Normally it 
is performed for 5 minutes in mice. The time at which immobility is 
achieved is recorded [25]. 
Open field test 
Another test to assess emotional behavior in rodents is an open field test. 
The mice were held gently by the tail and placed in centre of arena in 
open field. The activity of mice was observed for 10 minutes. 
During this experiment, we observed the number of times the mice 
moved in the centre square using all 4 paws and the number of 
peripheral squares crossed by mice on all 4 paws. 
Light and dark test  
This test was used to assess anxiety behavior in rodents. Rodents 
generally favor dark areas. The instinctive conflict between risk 
avoidance and exploratory drive is thought to inhibit exploration. 
The important feature that is observed is the change in willingness 
to explore the lightened unprotected area [26]. 
Statiatical analysis 
By taking mean of all the values, they are compared with means of 
control and the standard drug and by student significance t-test the 
significance of difference between means is determined. A value of 
p< 0.05 is considered significant, p< 0.001 as more significant and 
p< 0.0001 as highly significant. By Alcarz and Jimenez method all 
statistical procedures are performed [27]. 
RESULTS AND DISCUSSION 
Herbal preparations have been used since ancient civilizations as the 
source of medicinal agents because of their therapeutic efficacy, 
safety and low cost. Piper chaba a member of family piperaceae 
family is commonly found in tropical areas and possesses extensive 
pharmacological uses. 
Table 1.1 shows that when 300mg of Piper chaba was administered 
orally once daily. Significant decrease in cage crossing activity was 
observed after 7,14 and 21 days. From the above we can conclude 
that Piper chaba possesses CNS depressant effects. Previous studies 
show that locomotor activity is controlled by peripheral signals from 
spinal cord and brain area which plays a role in controlling 
movement and posture is the cerebellum [28]. 
Decreased locomotor activity indicates depressed CNS activity. It is 
known that GABA is major inhibitory neurotransmitter in CNS. The 
inhibitory effect is usually mediated by binding to GABAA receptor 
[29]. The mechanism of action of different anxiolytic drugs is by 
binding to GABAA receptor which causes chloride ions influx leading 
to hyperpolarization which reduces firing rate of critical neurons in 
brain [30]. Piperine is the main constituent of Piper species which 
possess CNS depressant effect [31]. Exact mechanism of action is not 
known but it can be postulated that it acts on GABAA
Table 2 shows there was a significant decrease in head dip activity 
by Piper chaba on acute dosing. Due to fear and neophobia animal 
tries to escape on initial exposure to the apparatus [36]. Elevated 
levels of corticosteroids in adult rats following first exposure to 
apparatus further confirms stressful condition of animal [37]. If it is 
assumed that on exposure to apparatus, anxiety develops due to 
state of fear so decrease in number of dips shows relieve from 
anxiety or reduced fear [38]. This postulation supports our above 
results that our extracts possess anxiolytic effect. 
 receptor; 
further work can be done on Piperchaba to evaluate its mechanism 
of action leading to CNS depression. 
Above postulation is further confirmed by the Open field test. Table 
1.2 shows the number of central square crosses was decreased after 
7, 14 and 21 day dosing of Piper chaba. Open field test is conducted 
to observe the exploratory behaviour, locomotor activity and anxiety 
in rodents. [32] Central square crossing is done to evaluate anxiety 
and exploratory behavior [33]. Our results showed reduced number 
of central square crossings indicating CNS depressant effect. 
Table 1.3 shows the number of peripheral square crosses were 
decreased after 7, 14 and 21 day dosing of Piper chaba. Peripheral 
square crossing is indicative of thigmotaxis a phenomenon in which 
due to fear and anxiety the mouse tries to stay near proximity of 
wall’s [34]. The results show decreased peripheral crossings 
indicating CNS depressant and anxiolytic activity. The increased 
frequency of urination and defecation has also been described as a 
marker of anxiety [35].  Our study indicates that after 21 day dosing 
of extract the urination and defecation frequency did not increase 
showing the extracts relieve anxiety. 
 
Table 1.1: Effect of Piper chaba on Exploratory Activity (Cage Crossing) 
Effect of Piper chaba on Cage Crossing 
Number of Cage Crosses 
 Day 7 Day 14 Day 21 
Groups Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 45.3±2.31   45.2 ± 1.75   47.1±1.73   
Standard 27.7±1.77   13.9± 1.66   7.8± 1.55   
Piper chaba 35.0±1.63 ***0.000 ***0.000 21.2± 1.03 ***0.000 ***0.000 13.6± 1.17 ***0.000 ***0.000 
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Table 1.2: Effect of Piper chaba on exploratory activity (Central Square Crossing) 
Effect of Piper chaba on Central square crosses in Open field test 
Number of Central square crosses 
 Day 7 Day 14 Day 21 
Groups Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 33.4±1.17   32.1 ± 1.45   30.7±1.06   
Standard 17.2±1.32   12.3± 1.37   5.0± 1.49   
Piper chaba 19.7±1.16 ***0.000 ***0.000 13.9± 1.37 ***0.000 *0.046 11.2± 1.03 ***0.000 ***0.000 
 
Table 1.3: Effect of Piper chaba on Exploratory activity (Peripheral Square Crosses) 
Effect of Piper chaba on Peripheral square crosses in Open field test 
Number of Peripheral square crosses 
 Day 7 Day 14 Day 21 
Groups Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 137±1.25   131.6 ± 1.78   138.7±1.49   
Standard 167.1±2.6   50.8± 2.94   15.1± 3.07   
Piper chaba 104.7± 1.49 ***0.000 ***0.000 84.4± 1.43 ***0.000 ***0.000 27.0± 1.49 ***0.000 ***0.000 
 
Table 2: Effect of Piper chaba on Anxiolytic activity (Head Dip Test) 
Effect of Piper chaba on Head Dip Activity 
Number of Head Dips 
Groups Day 7 Day 14 Day 21 
Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 34.5±1.58   33.8 ± 1.62   32.7±2.0   
Standard 34.4±1.17   17.9± 1.66   12.8± 1.75   
Piper chaba 21.9±1.79 ***0.000 ***0.000 17.0± 1.49 ***0.000 ***0.000 16.1± 1.6 ***0.000 ***0.000 
 
Table 2.1: Effect of Piper chaba on Anxiolytic activity (Light and Dark Test) 
Effect of Piper chaba on Light and Dark Activity 
Time spent in light box (sec) 
Groups Day 7 Day 14 Day 21 
Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 473.2±2.62   487± 1.49   485.1±1.45   
Standard 175.8±3.33   124± 3.4   16.1± 3.48   
Piper chaba 202.6± 1.9 ***0.000 ***0.000 182.5± 1.84 ***0.000 ***0.000 69.5± 1.08 ***0.000 ***0.000 
 
Table 3: Effect of Piper chaba on Anti-Depressant Activity. 
Effect of Piper chaba on Forced Swimming Test 
Struggling Time (sec) 
Groups Day 7 Day 14 Day 21 
Mean ± SD  P(control) P(STD) Mean ± SD P(control) P(STD) Mean ± SD P(control) P(STD) 
Control 92.7±2.0   84.8 ± 1.03   95.8±1.03   
Standard 60.1±1.66   30.10± 1.66   12.1± 1.52   
Piper chaba 53.0±2.45 ***0.000 ***0.000 38.5± 1.58 ***0.000 ***0.000 28.8± 1.48 ***0.000 ***0.000 
Values are mean ± S. D, N=10= number of animals, *p<0.05 = significant, ***p<0.0001 = highly significant , Following t-test and ANOVA df (2, 29) 
 
Anxiolytic or anxiogenic effects of drugs are also determined by light 
and dark test. In this the exploratory response of rodents is 
observed when exposed to stressors as light and changed 
environment as well as it focuses on instinctive nature of rodents to 
repel brightly illuminated area. [39] Research studies have shown 
that an animal who is stressesd or in fear or has anxiety tends to 
stay for prolonged period in darker area. He will not prefer to move 
and explore about the white box and peaking between two boxes 
will also be low. On the other hand anxiolytic drugs increase the 
number of transitions and the time spend in the white area [40].  
In acute dosing of Piper chaba we observed decreased number of 
transitions showing its CNS depressant effects. 
Table 3 shows that in Piper chaba treated mice the immobility state was 
achieved within seconds. Forced swim test is not only an indicator of 
anti-depressant effect of drugs but it is also used as an indicator of 
depression in rodents [41.]  
when mice become immobile after period of vigorous activity it 
represents depressive state.[42] A pathological complex of psychological, 
neuroendocrine and somatic symptoms is clinically represented as 
Depression[43]. This confirms CNS depressant activity of extract. GABAA 
α1
CONCLUSION 
 isoform mediates sedative and ataxic effects too [44]. The above 
results show reduced locomotor and sedative effect which is similar to 
effects produced by standard drug Lorazepam. 
From our research study we can conclude that after neuro 
pharmacological screening of ethanolic extract of fruit of Piper chaba 
after acute dosing we found that it possesses CNS depressant, Sedative 
and mild anxiolytic effect. Further studies can be conducted to evaluate 
its effect on specific regions of brain and neurotransmitters. 
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